dalteparin has been researched along with Catheter-Associated Infections in 1 studies
Dalteparin: A low-molecular-weight fragment of heparin, prepared by nitrous acid depolymerization of porcine mucosal heparin. The mean molecular weight is 4000-6000 daltons. It is used therapeutically as an antithrombotic agent. (From Merck Index, 11th ed)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aniort, J | 1 |
| Piraud, A | 1 |
| Adda, M | 1 |
| Perreira, B | 1 |
| Bouiller, M | 1 |
| Fourcade, J | 1 |
| Guerraoui, A | 1 |
| Kalbacher, E | 1 |
| Krumel, T | 1 |
| Moragues, HL | 1 |
| Thibaudin, D | 1 |
| Vela, CG | 1 |
| Vernin, G | 1 |
| Weclawiak, H | 1 |
| Bernard, L | 1 |
| Heng, AE | 1 |
| Souweine, B | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| "Evaluation of the Efficacy of an inTerdialytic Ethanol 40% v/v - enoxapaRin 1000 U/mL Lock solutioN to Prevent Tunnelled Catheter Infections in Chronic Hemodialysis Patients: a mulTi-centre, Randomized, Single Blind, Parallel Group studY (ETERNITY)"[NCT03083184] | Phase 3 | 400 participants (Anticipated) | Interventional | 2018-02-09 | Recruiting | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 trial available for dalteparin and Catheter-Associated Infections
| Article | Year |
|---|---|
Evaluation of the efficacy of an interdialytic "ethanol 40% v/v - enoxaparin 1000 U/mL" lock solution to prevent tunnelled catheter infections in chronic hemodialysis patients: a multi-centre, randomized, single blind, parallel group study.
Topics: Adult; Anti-Infective Agents, Local; Catheter-Related Infections; Catheters, Indwelling; Clinical Tr | 2019 |